Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

Related Citations for PubMed (Select 18975521)

1.

The effect of oral verapamil on the visual evoked potentials in multiple sclerosis patients.

Shafa MA, Hamzeimoghadam A, Shafiee K, Vakilian AR.

Acta Neurol Taiwan. 2008 Sep;17(3):162-6.

2.

Verapamil-induced changes in central conduction in patients with multiple sclerosis.

Gilmore RL, Kasarskis EJ, McAllister RG.

J Neurol Neurosurg Psychiatry. 1985 Nov;48(11):1140-6.

3.

Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.

Niklas A, Sebraoui H, Hess E, Wagner A, Then Bergh F.

Mult Scler. 2009 Jan;15(1):68-74. doi: 10.1177/1352458508095731. Epub 2008 Aug 13.

PMID:
18701569
4.
5.

Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.

Alshuaib WB.

Electromyogr Clin Neurophysiol. 2000 Jun;40(4):243-52.

PMID:
10907603
6.

A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.

Samsen P, Chuenkongkaew WL, Masayaanon P, Chirapapaisan N, Ruangvaravate N, Loket S.

J Med Assoc Thai. 2007 Feb;90(2):313-8.

PMID:
17375637
7.

[Pattern-reversal visual evoked potential abnormalities in patients with defined multiple sclerosis].

Andrade EP, Sacai PY, Berezovsky A, Salomão SR.

Arq Bras Oftalmol. 2007 Nov-Dec;70(6):943-8. Portuguese.

8.

Effects of hyperventilation on pattern-reversal visual evoked potentials in patients with demyelination.

Davies HD, Carroll WM, Mastaglia FL.

J Neurol Neurosurg Psychiatry. 1986 Dec;49(12):1392-6.

9.

Discriminative power of visual evoked potential characteristics in multiple sclerosis.

Cuypers MH, Dickson K, Pinckers AJ, Thijssen JM, Hommes OR.

Doc Ophthalmol. 1995;90(3):247-57.

PMID:
8846733
10.

[Visual evoked potential parameters in multiple sclerosis in developmental age].

Steczkowska M, Kroczka S, Biedroń A.

Przegl Lek. 2009;66(11):909-12. Polish.

PMID:
20297627
11.

Visual evoked potentials in differential diagnosis of multiple sclerosis and neurobehcet's disease.

Turker H, Terzi M, Bayrak O, Cengiz N, Onar M, Us O.

Tohoku J Exp Med. 2008 Oct;216(2):109-16.

12.
13.

N70 and P100 can be independently affected in multiple sclerosis.

Ghilardi MF, Sartucci F, Brannan JR, Onofrj MC, Bodis-Wollner I, Mylin L, Stroch R.

Electroencephalogr Clin Neurophysiol. 1991 Jan-Feb;80(1):1-7.

PMID:
1703943
14.

4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological study.

van Diemen HA, Polman CH, van Dongen MM, Nauta JJ, Strijers RL, van Loenen AC, Bertelsmann FW, Koetsier JC.

J Neurol Sci. 1993 Jun;116(2):220-6.

PMID:
8336169
15.

Decreased amplitudes in multiple sclerosis patients with normal visual acuity: a VEP study.

Diem R, Tschirne A, Bähr M.

J Clin Neurosci. 2003 Jan;10(1):67-70.

PMID:
12464525
16.

[Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].

Heun R, Emser W, Schimrigk K.

EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1989 Jun;20(2):88-91. German.

PMID:
2503359
17.

[Visual evoked potentials from different unpatterned stimuli in normal subjects and subjects with multiple sclerosis].

Cosi V, Erli LC, Callieco R.

Boll Soc Ital Biol Sper. 1981 Sep 30;57(18):1905-10. Italian.

PMID:
7317183
18.

Evoked potentials predict the clinical changes in a multiple sclerosis drug study.

Nuwer MR, Packwood JW, Myers LW, Ellison GW.

Neurology. 1987 Nov;37(11):1754-61.

PMID:
3313101
20.

Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.

Davis FA, Stefoski D, Rush J.

Ann Neurol. 1990 Feb;27(2):186-92.

PMID:
2317014
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk